Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02070211
Recruitment Status : Unknown
Verified February 2014 by Marco Armando, Bambino Gesù Hospital and Research Institute.
Recruitment status was:  Not yet recruiting
First Posted : February 25, 2014
Last Update Posted : February 25, 2014
Sponsor:
Collaborators:
National Alliance for Research on Schizophrenia and Depression
Orygen Youth Health Research Centre
Information provided by (Responsible Party):
Marco Armando, Bambino Gesù Hospital and Research Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : June 2016
Estimated Study Completion Date : June 2016